Table 2 Demographic Parameters and Cycle Outcomes of the Poseidon Subgroups (1a and 1b)
< 4 (N = 80) | 4–9 Oocytes (N = 324) | > 9 Oocytes (N = 602) | p | |
|---|---|---|---|---|
Age | 30.7 ± 2.7 | 29.9 ± 3.0 | 29.4 ± 2.9 | 0.01 |
BMI (kg/m2) | 24.3 ± 4.8 | 24.6 ± 4.7 | 24.9 ± 4.2 | 0.07 |
FSH (IU/L) | 5.7 (3.7–7.9) | 5.4 (4.1–6.7) | 5 (3.8–6.1) | < 0.01 |
Estradiol (ng/ml) | 58 (36–110) | 47 (31–83) | 43 (31–68) | 0.02 |
AMH (ng/ml) | 1.4 (1.2–2.1) | 1.8 (1.3–2.8) | 3.5 (2.2–5.4) | < 0.01 |
AFC (n) | 7 (6–9) | 9 (7–12) | 12 (9–17) | < 0.01 |
AFC – a | 5 (3–7) | 6 (4–8) | 8 (6–12) | < 0.01 |
AFC – b | 2 (1–4) | 3 (1–5) | 3 (1–6) | 0.143 |
Daily Gonadotropin Dose | 300 ± 55 | 300 ± 66 | 250 ± 67 | < 0.01 |
Estradiol on hCG day | 690 (341–1243) | 1148 (752–1740) | 2292 (1502–3368) | < 0.01 |
No. of Oocytes | 2 (1–3) | 7 (5–8) | 15 (12–20) | < 0.01 |
Metaphase-2 Oocytes | 1 (0–2) | 5 (4–7) | 12 (9–16) | < 0.01 |
No. of 2-Pronuclei Embryos | 1 (0–1) | 3 (1–4) | 7 (5–10) | < 0.01 |